FDMT
4d Molecular Therapeutics, Inc.
Clinical-stage gene therapy company
CUSIP: 35104E100HealthcareUS1 holder
Total Value
$61.60M
Total Shares
2.93M
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
Viking Global Investors
$61.60M2.93M sharesUnchanged